Location History:
- Thousand Oaks, CA (US) (2001 - 2006)
- Newbury Park, CA (US) (1999 - 2017)
Company Filing History:
26 out of 1,970 
4 out of 152 
3 out of 78 
Years Active: 1999-2017
Title: Exploring the Innovative Contributions of Francis Hall Martin
Introduction
Francis Hall Martin, based in Newbury Park, California, has made significant contributions to the field of biomedicine through his impressive portfolio of 28 patents. His work focuses primarily on monoclonal antibodies, specifically those that target the interleukin-1 receptor type 1 (IL-1R1), paving the way for advancements in treatments for IL-1 mediated diseases.
Latest Patents
Among his latest patents, Martin has developed therapeutic human anti-IL-1R1 monoclonal antibodies. These innovative antibodies have been demonstrated to interact effectively with IL-1R1. His patents describe methods of treating diseases mediated by IL-1 through the administration of a pharmaceutically effective amount of these antibodies. Additionally, he has outlined novel methods for detecting the amount of IL-1R1 in biological samples using these specific antibodies, further enhancing diagnostic and therapeutic strategies.
Career Highlights
Throughout his career, Martin has been associated with prominent companies in the biotechnology sector, including Amgen Inc. and Amgen Fremont Inc. His work in these organizations has allowed him to contribute substantially to medical research and therapeutic development. His expertise in monoclonal antibodies has positioned him as a pivotal figure in the advancement of targeted therapies.
Collaborations
Martin has collaborated with esteemed colleagues in the field, including Krisztina M. Zsebo and Robert A. Bosselman. These professional relationships highlight the collaborative nature of innovation in biomedicine, where diverse expertise converges to address complex medical challenges.
Conclusion
Francis Hall Martin's pioneering work exemplifies the importance of innovation in healthcare, particularly through the development of antibody therapies for IL-1 mediated diseases. His extensive portfolio of patents serves as a testament to his commitment to advancing medical science and improving patient outcomes. As research continues to evolve, Martin's contributions will undoubtedly play a critical role in shaping future therapeutic strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.